m+Medelevator.RU
← Поиск публикаций
Inflammation · 2026

Caveolin-2 Knockdown Alleviated Sepsis-induced Acute Lung Injury Via Promoting Macrophage M2 Polarization and Inhibiting Apoptosis by Hippo Signaling Pathway.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Xue Xiang, Gao Fei, Chen Juan, Wang Mengmeng, Wu Xinyao, Liao Haoyu, Sun Zhaorui, Nie Shinan

Аннотация

Sepsis-induced acute lung injury is a significant clinical challenge with high morbidity and mortality rates. Currently, no effective therapeutic interventions are available. The aim of this study was to elucidate the role and underlying mechanisms of Caveolin-2 in sepsis-induced acute lung injury. To this end, a Caveolin-2 knockdown model was utilized both in vivo and in vitro, facilitating a comprehensive evaluation of several parameters, including lung tissue injury, inflammatory responses, oxidative stress markers, changes in apoptotic protein expression, and indicators of macrophage polarization. Additionally, the study investigated alterations in proteins associated with the Hippo signaling pathway and assessed the effects of Hippo pathway inhibitors on apoptosis and polarization. Our results indicate that the knockdown of Caveolin-2 facilitates the polarization of macrophages towards the protective M2 macrophage polarization and mitigates macrophage apoptosis. This process is associated with a reduction in oxidative stress and inflammatory responses, culminating in the activation of the Hippo signaling pathway. Conversely, the overexpression of Caveolin-2 intensifies inflammation and oxidative damage, while promoting apoptosis and M1 macrophage polarization. Our findings provide novel insights into the role of Caveolin-2 and Hippo signal pathway in sepsis-induced acute lung injury and establish a foundation for future research and the development of potential therapeutic strategies.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты